Royce & Associates LP Optimize Rx Corp Transaction History

Royce & Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$35.27 - $62.91 $1.55 Million - $2.77 Million	44,000 New	44,000 $1.66 Million
Q4 2021 Feb 07, 2022	SELL	$53.57 - $98.0 $613,376 - $1.12 Million	-11,450 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$50.93 - $85.55 $700,287 - $1.18 Million	-13,750 Reduced 54.56%	11,450 $980,000
Q2 2021 Aug 06, 2021	BUY	$42.76 - $63.33 $34,208 - $50,664	800 Added 3.28%	25,200 $1.56 Million
Q1 2021 May 10, 2021	BUY	$33.36 - $62.2 $50,040 - $93,300	1,500 Added 6.55%	24,400 $1.19 Million
Q4 2020 Feb 08, 2021	BUY	$19.04 - $33.1 $55,216 - $95,990	2,900 Added 14.5%	22,900 $714,000
Q3 2020 Nov 12, 2020	BUY	$12.99 - $21.78 $66,249 - $111,078	5,100 Added 34.23%	20,000 $417,000
Q2 2020 Aug 07, 2020	BUY	$8.34 - $13.69 $124,266 - $203,981	14,900 New	14,900 $194,000

13.3M

79.8K

41.4K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $140M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.